Recurrence of autoimmunity in islet transplant recipients by evaluation of GAD65 and IA2 autoantibodies

被引:0
|
作者
Mineo, Davide [1 ,2 ]
Monroy, Kathy [1 ]
Allende, Gloria [1 ]
Cure, Pablo [1 ]
Leitao, Cristiane [1 ]
Baidal, David A. [1 ]
Bernetti, Karina [1 ]
Tharavanij, Thipaporn [1 ]
Faradji, Raquel N. [1 ]
Froud, Tatiana [1 ]
Burke, George W. [1 ]
Ricordi, Camillo [1 ]
Pugliese, Alberto [1 ]
Alejandro, Rodolfo [1 ]
机构
[1] Univ Miami, Diabet Res Inst, Coral Gables, FL 33124 USA
[2] Univ Roma Tor Vergata, Dept Med, Rome, Italy
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:434 / 435
页数:2
相关论文
共 50 条
  • [41] Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis
    Pilia, S.
    Casini, M. R.
    Cambuli, V. M.
    Ibba, A.
    Civolani, P.
    Zavattari, P.
    Incani, M.
    Mossa, P.
    Baroni, M. G.
    Mariotti, S.
    Loche, S.
    DIABETIC MEDICINE, 2011, 28 (08) : 896 - 899
  • [42] GAD 65 and IA2 antibody levels predict future β-cell failure in adult onset diabetes
    Borg, H
    Gottsäter, A
    Landin-Olsson, M
    Fernlund, P
    Sundkvist, G
    DIABETOLOGIA, 2000, 43 : A109 - A109
  • [43] Human anti-IA-2 autoantibodies isolated from an immune library by phage display are able to bind to both major autoantigens: GAD65 and IA-2
    Valera, L.
    Peraldi-Roux, S.
    Watelet-Jardin, B.
    Lampasona, V.
    Granier, C.
    Bonifacio, E.
    Laune, D.
    DIABETOLOGIA, 2007, 50 : S30 - S30
  • [44] Four HLA-DQ heterodimers are potent risk factors for IDDM in the absence of GAD65, IA-2 and islet cell antibodies
    Pietropaolo, M
    Rudert, WA
    Laporte, RE
    Becker, DJ
    Trucco, M
    DIABETES, 1998, 47 : A209 - A209
  • [45] Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies
    Schranz, DB
    Bekris, L
    Landin-Olsson, M
    Törn, C
    Niläng, A
    Toll, Å
    Sjöström, J
    Grönlund, H
    Lernmark, Å
    HORMONE AND METABOLIC RESEARCH, 2000, 32 (04) : 133 - 138
  • [46] Prevalence of GAD(65) and IA-2 autoantibodies in IDDM patients with nephropathy.
    Zerbini, G
    Bazzigaluppi, E
    Mangili, R
    Bosi, E
    Bonifacio, E
    DIABETOLOGIA, 1997, 40 : 2090 - 2090
  • [47] GAD, IA2 and insulin autoantibodies in children diagnosed with acute lymphoblastic leukaemia: Relevance for type 1 diabetes
    Pozzilli, Paolo
    Astorri, Elisa
    Bizzari, Carla
    Cappa, Marco
    De Rossi, Giulio
    Leslie, Richard D. G.
    Hawa, Mohammed
    Spoletini, Maria Luisa
    Buzzetti, Raffaella
    DIABETES, 2006, 55 : A412 - A412
  • [48] Prevalence of anti-GAD and IA2 autoantibodies in a French cohort of patients with diabetes eligible for bariatric surgery
    Martin, C.
    Boudaoud, A. Ait
    Poghosyan, T.
    Zhu, J.
    Larger, E.
    Greenfield, J. R.
    Czernichow, S.
    Rives-Lange, C.
    Carette, C.
    DIABETES & METABOLISM, 2020, 46 (05) : 407 - 409
  • [49] Independent Associations of GAD65, IA2, and ZnT8 Autoantibody (Ab) Positivity with C-Peptide (CPep) in a Diverse Cohort of Youth with Diabetes (DM)
    Redondo, Maria J.
    Harrall, Kylie K.
    Glueck, Deborah H.
    Tosur, Mustafa
    Uysal, Serife
    Muir, Andrew
    Vehik, Kendra
    Brusko, Todd M.
    Atkinson, Mark A.
    Oram, Richard A.
    Dabelea, Dana
    Hagopian, William
    DIABETES, 2023, 72
  • [50] Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: A study of Chinese patients with diabetes mellitus
    Ng, WY
    Lee, YS
    Todd, AL
    Liu, KF
    Loke, KY
    Thai, AC
    AUTOIMMUNITY, 2002, 35 (02) : 119 - 124